Fresh urine pellets from human immunodeficiency virus type 1 (HIV-1)-seropositive individuals were examined for the presence of the HIV-1 genomic sequence and gene products. By using the polymerase chain reaction technique, HIV-1 DNA proviral sequences were detected in 53 of 80 (66.25%) fresh urine pellets from HIV-1-seropositive individuals, while urine pellets from all 24 healthy heterosexual controls were negative. HIV-1 RNA in urine pellets was detected by reverse transcriptase polymerase chain reaction in 2 of 43 (4.7%) HIV-1-seropositive individuals. In addition, HIV-1 p24 core antigen was demonstrated in 3 of 80 urine pellets from HIV-1-seropositive individuals by enzyme-linked immunosorbent assay. Moreover, HIV-1 p24 core antigen and HIV-1 RNA were shown in the cellular component of urine pellets from HIV-1-seropositive individuals by immunohistochemical staining and in situ hybridization. These results indicate that HIV-1 can be present in urine pellets from HIV-1-infected individuals.
Human immunodeficiency virus type 1 (HIV-1), the etiological agent of AIDS, has been isolated from several body fluids of infected individuals (6, 9, 10, 23, 25) . We have previously shown the prevalence of specific immunoglobulin G antibody to HIV-1 in the urine of HIV-1-seropositive individuals by enzyme-linked immunosorbent assay (ELISA) and Western immunoblot assay (3) . In addition, we recently reported the presence of HIV-1 proviral DNA sequences in urine cell pellets from HIV-1-infected individuals (14) . We describe here the detection of HIV-1-specific proviral DNA and RNA in centrifuged fresh urine pellets from some HIV-1-seropositive individuals. Moreover, the mononuclear cells present within these urine pellets contained HIV-1 DNA, RNA, and p24 core protein, as demonstrated by in situ hybridization, immunohistochemical staining, and ELISA.
MATERIALS AND METHODS
Blood and urine samples were collected from 80 randomly selected HIV-1-seropositive homosexual males attending a clinic at New York University Medical Center. Among them, 19 were healthy, asymptomatic HIV-1-seropositive individuals, 17 had AIDS-related complex, 40 had AIDSrelated Kaposi's sarcoma, and 4 had AIDS associated with an opportunistic infection. Twenty-four healthy HIV-1-seronegative heterosexual male employees of the New York University Medical Center served as normal controls. Urine samples from all patients were found to be within normal limits by routine urinalysis. In addition, the blood urea nitrogen and creatinine levels in all patients were in the normal range.
Mononuclear cells from peripheral blood were separated by gradient centrifugation with Ficoll-Hypaque. Cell pellets from -100-ml fresh urine specimens were obtained by centrifugation at 1,200 x g at 4°C for 5 min and were then washed twice with phosphate-buffered saline (PBS). The DNA and RNA samples were extracted from urine pellets of different specimens from each individual as described previ-* Corresponding author.
ously (16) . DNAs were dialyzed in dialysis bags with 10 mM Tris-Cl-1 mM EDTA (TE) overnight and were then precipitated with ethanol.
The polymerase chain reaction (PCR) amplification method was then performed on these specimens with DNA and 10 pmol of each of the HIV-1 gag gene primers (SK38 and SK39) in a buffer containing 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 1.5 mM MgCl2, 100 ,ug of gelatin per ml, 2.5 U of Taq polymerase, and 225 ,uM (each) deoxynucleoside triphosphates. Samples were subjected to 30 cycles of denaturation (94°C, 1 min), annealing (55°C, 1 min), and extension (72°C, 1 min). The PCR products were analyzed by either slot blot hybridization or liquid hybridization (1) Gaithers- burg, Md.) was then added for 2 h at room temperature, and then horseradish peroxidase-streptavidin (Boehringer Mannheim Biochemicals, Indianapolis, Ind.) was added and the slides were incubated for an additional 30 min at room temperature. Between each incubation the slide smears were washed twice for 5 min each time in PBS. As a substrate solution we used 0.2 mg of 3,3-diaminoberyidine (Polysciences Inc., Warrington, Pa.) per ml in PBS (pH 7.4) supplemented with 0.1% hydrogen peroxide. Finally, the slides were counterstained with hematoxylin and examined by microscopy (8, 19) . HIV-1-infected H9 cells served as positive controls, while noninfected H9 cells, normal control urine cell pellets smeared onto slides, and HIV-1-infected cells incubated with normal mouse serum served as negative controls.
In situ hybridization. Fresh urine pellets were fixed on poly-L-lysine-coated slides and were then treated with 0.2 N HCl for 20 min at room temperature. The slides were washed and then treated with proteinase K (1 pg/ml) for 5 min at 37°C. After rinsing in 2x SSC (lx SSC is 0.15 M NaCl plus 0.015 M sodium citrate), the slides were treated with 0.25% (vol/vol) acetic anhydride in triethanolamine for 10 min and were then washed in 2x SSC at room temperature for 5 min.
The slides were covered with prehybridization buffer (2x SSC containing Denhardt's solution [0.02% Ficoll-400, 0.02% bovine serum albumin, 0.02% polyvinylpyrrolidone-40] and 10% dextran sulfate in 20 mM sodium phosphate [pH 7.2]) for 1 h at 37°C. After washing, the slides were covered by the hybridization solution, which contained 50% formamide, 10% dextran sulfate, lx Denhardt's solution, 1 mg of yeast tRNA per ml, 100 ,ug of salmon sperm DNA per ml, and 5 x 105 cpm of 35S-labeled HIV-1 RNA (NEN/Dupont) incubated at 37°C overnight. The slides were rinsed in 2x SSC twice at room temperature and were then washed again in 2x SSC at 55°C for 1 h. The slides were then washed with 50% formamide-0.6 M NaCl-100 mM Tris-1 mM EDTA at room temperature. After washing, the autoradiographic detection of hybrids was carried out by dipping the slides in Kodak NTB2 emulsion diluted 1:1 with distilled water containing 0.3 M ammonium acetate. The urine pellet-smeared slides were allowed to air dry and were then placed in a desiccation chamber at 4°C for 1 to 4 weeks. The slides were subsequently developed in Kodak D19 developer and were stained with hematoxylin and eosin (5, 13, 15) .
ELISA for HIV-1 p24 antigen in urine pellets. Eighty urine pellets were collected from fresh urine by centrifugation at 1,200 x g. The pellets were then suspended in 200 pd of PBS and were lysed by repeated freezing and thawing. After microcentrifugation at 10,000 x g, the supernatants were then assayed for the presence of HIV-1 p24 core protein antigen by an antigen capture enzyme immunoassay (Abbott Laboratories, North Chicago, Ill.). Representative PCR analysis of peripheral blood mononuclear cell and urine cell pellets. DNAs were amplified with primer pair SK38-SK39 and were detected with the SK19 probe as described in the text. The slot blots contained PCR products from the following samples: Al to A6, peripheral blood mononuclear cells from HIV-1-seropositive patients; B1 to B6, fresh urine pellets from HIV-1-seropositive patients; Cl to C6 and Dl to D6, peripheral blood mononuclear cell and urine cell pellets, respectively, from healthy controls; El, human placenta DNA; E2, primer pair control; E3, HIV-1-infected H9 cells as a positive control. sarcoma, 3 of 4 (75%) patients with AIDS and an opportunistic infection, and 11 of 19 (58%) healthy, asymptomatic individuals. Urine pellets from all 24 healthy controls were negative for HIV-1 DNA by PCR (Fig. 1) .
HIV-1 RNA in the urine pellets was detected by the RT-PCR method (2) . Among the fresh urine pellets from 43 HIV-1-seropositive individuals, 2 (4.7%) showed positive signals by RT-PCR (Fig. 2) .
To confirm that the urine pellets contained HIV-1, immunohistochemical staining and in situ hybridization were performed on the same urine pellets. As shown in Fig. 3 and 4, p24 antigen was detected in the cellular component of the fresh urine pellets by monoclonal antibody immunohistochemical staining. The p24 antigen was not detected in any of the fresh urine pellets from HIV-1-uninfected healthy individuals. The antibody staining for p24 was found to be confined to only a few of the mononuclear cells found in the urine pellets. Only 3 of 80 urine specimens from the HIV-1-seropositive individuals were found to be p24 antigen positive by ELISA performed on the supernatants of lysed urine pellets. The level of the p24 core protein detected in these specimens ranged from 31 to 1,000 pg/ml.
By the in situ hybridization method, use of the 35S-labeled HIV-1 probe resulted in a strong hybridization signal in HIV-1-infected H9 lymphocyte cultures, and positive signals were also detected in the cells that were present in 2 of 10 urine pellets from HIV-1-seropositive individuals (Fig. 4) . 
DISCUSSION
It has been demonstrated previously that normal human urine frequently contains small amounts of mononuclear cells and erythrocytes. Detection of infectious organisms such as JC virus, cytomegalovirus, human papillomavirus, and Leptospira spp. in urine has been reported previously (4, 18, 20, 24) . HIV-1 has previously been isolated from various body fluids from HIV-1-seropositive individuals, including blood, semen, tears, saliva, cerebrospinal fluid, breast milk, and cervical secretions (6, 7, 9-11, 23, 25) . With the increasing incidence of HIV-1 infection, the question of whether infectious HIV-1 can be detected in urine from infected individuals becomes increasingly important, since urine could serve as a vehicle for HIV-1 transmission. Levy et al. (12) A broad spectrum of renal diseases has been described in HIV-1-infected patients with symptomatic HIV-1 disease (17) . In particular, attention has been focused on a nephropathy that is clinically characterized by nephrotic syndrome and rapidly advancing renal insufficiency which, by histopathologic examination, is associated with focal and diffuse glomerular sclerosis (21) . Chronic urinary tract infections may also occur in immunosuppressed, HIV-1-infected hosts (17) . The HIV-1-infected patients who we studied were all found to have normal renal function by routine urinalyses and normal serum blood urea nitrogen and creatinine levels; however, the possibility of either subclinical renal disease or urinary tract infection could not be totally ruled out.
By the PCR method, both HIV-1 proviral DNA and RNA were demonstrated in different urine pellets collected from each of the HIV-1-seropositive individuals studied, but the positive ratio for HIV-1 DNA and HIV-1 RNA was much lower than that detected in the corresponding patients' blood samples. The HIV-1-positive results obtained by PCR reflected a relatively low incidence of HIV-1-containing cells in urine pellets from HIV-1-infected individuals. Because of the hypersensitivity of the PCR method, we also examined the urine pellets for HIV-1 by immunohistochemical staining and in situ hybridization methods. Some mononuclear cells found in the urine pellets contained both HIV-1 viral RNA and p24 protein; in three cases, we were able to demonstrate by ELISA the presence of p24 antigen in the lysed urine pellet. Our data show that HIV-1 proviral DNA and RNA and HIV-1 gene products, such as the p24 core protein, can be present in urine pellets from HIV-1-infected individuals. On the basis of these observations, the question of whether urine is potentially an infectious body fluid in the HIV-1-infected host is raised. In their attempts to isolate infectious HIV-1 from urine, other investigators have not been able to culture infectious HIV-1 from the urine of HIV-1-seropositive individuals (22) . However, our results demonstrate that HIV-1 genomic sequences can, in fact, be detected in centrifuged urine cells pellets from some seropositive individuals.
By the PCR technique, it is theoretically possible to detect HIV-1 proviral DNA sequences in the centrifuged pellets of fresh urine specimens from HIV-1-seropositive individuals. Previous studies in which PCR was used to detect HIV-1 sequences have focused almost exclusively on blood samples from HIV-1-infected individuals. The demonstration that HIV-1 proviral DNA and RNA sequences can be detected in urine cell pellets by the PCR technique might be useful as a noninvasive test for confirming HIV-1 infection.
